GlassScriptPhysician profile
James B Knox
NPI 1386691178
$1,703.52
in general payments reported to CMS, 2019-2025
13 companies · $23.15 in 2025
The $23.15 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2021: $718 · 2022: $262 · 2023: $267 · 2024: $93.05 · 2025: $23.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $755.51 | 2021-2022 | |
| Organogenesis INC. | $191.80 | 2019 | |
| Koya Medical, INC. | $123.41 | 2023 | Dayspring |
| Smith+Nephew, INC. | $113.95 | 2023-2024 | Grafix Pl, Collagenase Santyl, Iodosorb Ointment 40g USA |
| W. L. Gore & Associates, INC. | $106.51 | 2022 | |
| Cook Medical LLC | $103.06 | 2019 | |
| Boston Scientific Corporation | $78.47 | 2021-2023 | Varithena Administration Pack |
| Janssen Pharmaceuticals, INC | $65.72 | 2019-2022 | |
| Integra Lifesciences Corporation | $47.83 | 2021 | |
| Angiodynamics, INC. | $43.17 | 2023 | Venacure 1470 Pro |
| Ets Wound Care LLC | $29.96 | 2024 | Mirragen Advanced Wound Matrix |
| Urgo Medical North America, LLC | $23.15 | 2025 | Urgok2 |
| Aroa Biosurgery Incorporated | $20.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Knox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.